Nanox Q2 2026: 10 Partners, Cost Cuts, Class Action Risk
Investors should weigh Nanox's commercialization claims against a securities class action and limited disclosed financials. The company highlights distribution growth and capital raised, but the press release lacks specific revenue or EPS figures.
Source: Globenewswire_fr · Financialcontent